Capital Markets: Equity
UK Guide 2025 : UK-wide
Band 4
Contact number
+44 207 071 4000Chambers Review
Gibson Dunn & Crutcher fields a well-regarded team that is noted for its expertise in both cross-border and domestic capital market matters. The firm principally advises issuers on IPOs and equity placings and possesses notable expertise in the technology sector.
Work Highlights
- Gibson Dunn advised Gamma Biosciences on the USD215 million sale of its operating company, Astrea Bioseparations, in exchange for newly issued consideration shares in Biotage AB.
Strengths
Provided by Chambers
"The firm provides pragmatic and commercially-focused advice."
"The team has real depth of skills and always provides excellent advice."
"The firm provides pragmatic and commercially-focused advice."
"The team has real depth of skills and always provides excellent advice."
Notable Practitioners
Christopher Haynes is adept at handling equity transactions, including share sales and private financing. IPOs are another strength and he is sought out by both banks and companies for his expertise.
"Christopher is thoughtful and pragmatic."
"He is very commercial."